Maale Adumim, Israel

Isaac Milman


Average Co-Inventor Count = 4.6

ph-index = 4

Forward Citations = 80(Granted Patents)


Location History:

  • Maale Adumin, IL (1994)
  • Maale Adumim, IL (1996 - 1997)

Company Filing History:


Years Active: 1994-1997

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Isaac Milman: Innovator in Pharmaceutical Chemistry

Introduction

Isaac Milman is a notable inventor based in Maale Adumim, Israel. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on developing innovative compounds for medical applications.

Latest Patents

Milman's latest patents include the development of polyamine derivatives of 1-aminoindan. This compound is characterized by a general formula where n is either 1 or 2, and R1 and R2 can be various chemical groups. Another significant patent involves L-DOPA ethyl ester, which is aimed at treating Parkinson's disease. This treatment involves administering a composition that contains L-DOPA ethyl ester as the active ingredient, ensuring a high concentration for effective patient care.

Career Highlights

Throughout his career, Milman has worked with prominent companies such as Teva Pharmaceutical Industries Limited and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical sector.

Collaborations

Milman has collaborated with esteemed colleagues, including Alexander Veinberg and Daphne Atlas. These partnerships have further enhanced his research capabilities and innovation potential.

Conclusion

Isaac Milman stands out as a significant figure in pharmaceutical innovation, with a focus on developing effective treatments for serious medical conditions. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…